SCHEMBL3962923

SCHEMBL3962923

Oc1ccc(CC(O)Nc2cc(-c3cccnc3)nc(-c3ccccn3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
TP53 P04637 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 3/20 0.39
CYP2C9 P11712 1/20 0.39
CYP19A1 P11511 2/20 0.38
HIF1A Q16665 1/20 0.38
CYP1A2 P05177 3/20 0.38
CYP2D6 P10635 2/20 0.38
CLK4 Q9HAZ1 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
GLA P06280 1/20 0.38
POLB P06746 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SLC2A1 P11166 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2239081 0.83 CLK4 (0.54) CYP2A6SMN1; SMN2CYP3A4CYP2C9HIF1A
SCHEMBL2242475 0.82 PTGDR (0.54) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL4773513 0.81 CYP2A6 (0.44) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL4773536 0.81 CYP2A6 (0.44) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL4775017 0.81 CYP2A6 (0.44) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL2235864 0.80 CYP2D6 (0.44) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL4773489 0.78 CYP3A4 (0.39) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL4766379 0.76 CYP2A6 (0.46) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL3962124 0.76 CYP2A6 (0.46) CYP2A6NPC1RAB9ATP53PKM
SCHEMBL4766345 0.76 CYP2A6 (0.46) CYP2A6NPC1RAB9ATP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP claimed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO claimed
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP disclosed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO disclosed